---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-000246"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2025-01-03T23:59:59+00:00"
generated_at: "2026-05-28T16:29:22.574630+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics receives Nasdaq bid price deficiency notice; 180-day cure period until June 30, 2025

## Summary
- Notice received December 30, 2024: closing bid price below $1 for 30 consecutive business days.
- Company has until June 30, 2025 to regain compliance for 10 consecutive business days.
- If not cured, may request a second 180-day period if other listing standards are met.
- Stock continues to trade on Nasdaq under symbol ERNA with no immediate delisting.

## SEC filing metadata
- accession: 0001493152-25-000246
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2025-01-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315225000246/0001493152-25-000246-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315225000246/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-000246
- JSON: https://secwatch.observer/filing/0001493152-25-000246.json
- Plain text: https://secwatch.observer/filing/0001493152-25-000246.txt

## Source-grounded claims
- claim_id: b116a62cc6636c9575e90d98e5b965b5438a5a7a
  claim: Ernexa Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: December 30, 2024, Eterna Therapeutics Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Staff (“Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closi
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000149315225000246/0001493152-25-000246-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.